Prot #DRM06-AD17: An Open-Label, Single Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

Project: Research project

Project Details

StatusActive
Effective start/end date2/2/212/2/24

Funding

  • INC Research, LLC (Prot #DRM06-AD17)
  • Lilly USA, LLC (Prot #DRM06-AD17)